Biography and Research Information
OverviewAI-generated summary
AyoOluwa O. Olubamiwa's research focuses on understanding the mechanisms behind drug-induced liver injury (DILI). This work investigates the roles of drug metabolizing enzymes and transporters in the development of DILI. Olubamiwa has contributed to the DILIrank database, an updated resource for assessing DILI risk based on FDA labeling and literature reviews. Collaborations with researchers at the National Center for Toxicological Research, including Minjun Chen, Tsung‐Jen Liao, and Skylar Connor, have supported this line of inquiry. Olubamiwa's work is also exploring how drug interactions with UDP-Glucuronosyltransferase (UGT) enzymes can serve as a predictor for DILI.
Metrics
- h-index: 2
- Publications: 3
- Citations: 21
Selected Publications
-
DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review (2025)
-
Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury (2024)
Collaboration Network
Top Collaborators
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
Similar Researchers
Based on overlapping research topics